다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Molecules a journal of synthetic chemistry and natural product chemistry, v.22 no.9, 2017년, pp.1570 -
Reinbold, Jochen (Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tuebingen, 72076 Tuebingen, Germany) , Uhde, Ann-Kristin (stefanie.krajewski@uni-tuebingen.de (J.R.)) , Müller, Ingrid (ann-kristin.uhde@student.uni-tuebingen.de (A.-K.U.)) , Weindl, Tobias (christian.schlensak@med.uni-tuebingen.de (C.S.)) , Geis-Gerstorfer, Jürgen (hans-peter.wendel@med.uni-tuebingen.de (H.-P.W.)) , Schlensak, Christian (Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tuebingen, 72076 Tuebingen, Germany) , Wendel, Hans-Peter (stefanie.krajewski@uni-tuebingen.de (J.R.)) , Krajewski, Stefanie (ann-kristin.uhde@student.uni-tuebingen.de (A.-K.U.))
AI-Helper
Surgical site infections (SSIs) are one of the most common nosocomial infections, which can result in serious complications after surgical interventions. Foreign materials such as implants or surgical sutures are optimal surfaces for the adherence of bacteria and subsequent colonization and biofilm ...
1. De Simone S. Gallo A.L. Paladini F. Sannino A. Pollini M. Development of silver nano-coatings on silk sutures as a novel approach against surgical infections J. Mater. Sci. Mater. Med. 2014 25 2205 2214 10.1007/s10856-014-5262-9 24997984
2. Gallo A.L. Paladini F. Romano A. Verri T. Quattrini A. Sannino A. Pollini M. Efficacy of silver coated surgical sutures on bacterial contamination, cellular response and wound healing Mater. Sci. Eng. C Mater. Biol. Appl. 2016 69 884 893 10.1016/j.msec.2016.07.074 27612783
3. Lenz A.M. Fairweather M. Cheadle W.G. Resistance profiles in surgical-site infection Future Microbiol. 2008 3 453 462 10.2217/17460913.3.4.453 18651816
4. Katz S. Izhar M. Mirelman D. Bacterial adherence to surgical sutures. A possible factor in suture induced infection Ann. Surg. 1981 194 35 41 10.1097/00000658-198107000-00007 7018429
5. Shunmugaperumal T. Microbial colonization of medical devices and novel preventive strategies Recent Pat. Drug Deliv. Formul. 2010 4 153 173 10.2174/187221110791185006 20236065
6. Klose D. Siepmann F. Willart J.F. Descamps M. Siepmann J. Drug release from PLGA-based microparticles: Effects of the ‘microparticle:bulk fluid’ ratio Int. J. Pharm. 2010 383 123 131 10.1016/j.ijpharm.2009.09.012 19748558
7. Ignatius A.A. Claes L.E. In vitro biocompatibility of bioresorbable polymers: Poly( l , dl -lactide) and poly( l -lactide- co -glycolide) Biomaterials 1996 17 831 839 10.1016/0142-9612(96)81421-9 8730968
8. Shive M.S. Anderson J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Deliv. Rev. 1997 28 5 24 10837562
9. Hu C. Feng H. Zhu C. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system Colloids Surf. B Biointerfaces 2012 95 162 169 10.1016/j.colsurfb.2012.02.030 22424828
10. Marquette S. Peerboom C. Yates A. Denis L. Langer I. Amighi K. Goole J. Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres Int. J. Pharm. 2014 470 41 50 10.1016/j.ijpharm.2014.04.063 24792974
11. Muroi H. Kubo I. Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus J. Appl. Bacteriol. 1996 80 387 394 10.1111/j.1365-2672.1996.tb03233.x 8849640
12. Kubo I. Muroi H. Himejima M. Antibacterial activity of totarol and its potentiation J. Nat. Prod. 1992 55 1436 1440 10.1021/np50088a008 1453180
13. Nicolson K. Evans G. O’Toole P.W. Potentiation of methicillin activity against methicillin-resistant Staphylococcus aureus by diterpenes FEMS Microbiol. Lett. 1999 179 233 239 10.1111/j.1574-6968.1999.tb08733.x 10518721
14. Haraguchi H. Oike S. Muroi H. Kubo I. Mode of antibacterial action of totarol, a diterpene from Podocarpus nagi Planta Med. 1996 62 122 125 10.1055/s-2006-957832 8657742
15. Smith E.C. Kaatz G.W. Seo S.M. Wareham N. Williamson E.M. Gibbons S. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus Antimicrob. Agents Chemother. 2007 51 4480 4483 10.1128/AAC.00216-07 17664318
16. Micol V. Mateo C.R. Shapiro S. Aranda F.J. Villalain J. Effects of (+)-totarol, a diterpenoid antibacterial agent, on phospholipid model membranes Biochim. Biophys. Acta 2001 1511 281 290 10.1016/S0005-2736(01)00284-X 11286971
17. Jaiswal R. Beuria T.K. Mohan R. Mahajan S.K. Panda D. Totarol Inhibits Bacterial Cytokinesis by Perturbing the Assembly Dynamics of FtsZ Biochemistry 2007 46 4211 4220 10.1021/bi602573e 17348691
18. Haraguchi H. Ishikawa H. Kubo I. Antioxidative action of diterpenoids from Podocarpus nagi Planta Med. 1997 63 213 215 10.1055/s-2006-957655 9225601
19. Reinbold J. Hierlemann T. Hinkel H. Muller I. Maier M.E. Weindl T. Schlensak C. Wendel H.P. Krajewski S. Development and in vitro characterization of poly(lactide- co -glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections Drug Des. Dev. Ther. 2016 10 2823 2832 27660414
20. Watanabe A. Kohnoe S. Shimabukuro R. Yamanaka T. Iso Y. Baba H. Higashi H. Orita H. Emi Y. Takahashi I. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery Surg. Today 2008 38 404 412 10.1007/s00595-007-3637-y 18560962
21. Engelsman A.F. van der Mei H.C. Ploeg R.J. Busscher H.J. The phenomenon of infection with abdominal wall reconstruction Biomaterials 2007 28 2314 2327 10.1016/j.biomaterials.2007.01.028 17306365
22. Dennis C. Sethu S. Nayak S. Mohan L. Morsi Y.Y. Manivasagam G. Suture materials—Current and emerging trends J. Biomed. Mater. Res. Part A 2016 104 1544 1559 10.1002/jbm.a.35683 26860644
23. Zimmerli W. Waldvogel F.A. Vaudaux P. Nydegger U.E. Pathogenesis of foreign body infection: Description and characteristics of an animal model J. Infect. Dis. 1982 146 487 497 10.1093/infdis/146.4.487 7119479
24. Justinger C. Moussavian M.R. Schlueter C. Kopp B. Kollmar O. Schilling M.K. Antibacterial [corrected] coating of abdominal closure sutures and wound infection Surgery 2009 145 330 334 10.1016/j.surg.2008.11.007 19231586
25. Yueh M.F. Tukey R.H. Triclosan: A Widespread Environmental Toxicant with Many Biological Effects Annu. Rev. Pharmacol. Toxicol. 2016 56 251 272 10.1146/annurev-pharmtox-010715-103417 26738475
26. Calafat A.M. Ye X. Wong L.Y. Reidy J.A. Needham L.L. Urinary concentrations of triclosan in the U.S. population: 2003–2004 Environ. Health Perspect. 2008 116 303 307 10.1289/ehp.10768 18335095
27. Shi C. Zhao X. Li W. Meng R. Liu Z. Liu M. Guo N. Yu L. Inhibitory effect of totarol on exotoxin proteins hemolysin and enterotoxins secreted by Staphylococcus aureus World J. Microbiol. Biotechnol. 2015 31 1565 1573 10.1007/s11274-015-1905-3 26193949
28. Li Y. Kumar K.N. Dabkowski J.M. Corrigan M. Scott R.W. Nusslein K. Tew G.N. New bactericidal surgical suture coating Langmuir 2012 28 12134 12139 10.1021/la302732w 22877364
29. Makadia H.K. Siegel S.J. Poly Lactic- co -Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier Polymers 2011 3 1377 1397 10.3390/polym3031377 22577513
30. Dhas S.P. Anbarasan S. Mukherjee A. Chandrasekaran N. Biobased silver nanocolloid coating on silk fibers for prevention of post-surgical wound infections Int. J. Nanomed. 2015 10 Suppl. 1 159 170
31. Meghil M.M. Rueggeberg F. El-Awady A. Miles B. Tay F. Pashley D. Cutler C.W. Novel Coating of Surgical Suture Confers Antimicrobial Activity Against Porphyromonas gingivalis and Enterococcus faecalis J. Periodontol. 2015 86 788 794 10.1902/jop.2015.140528 25703732
32. Obermeier A. Schneider J. Fohr P. Wehner S. Kuhn K.D. Stemberger A. Schieker M. Burgkart R. In vitro evaluation of novel antimicrobial coatings for surgical sutures using octenidine BMC Microbiol. 2015 15 10.1186/s12866-015-0523-4 26404034
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.